Auto-apply Knowledge-Skills-Behaviors framework to guide Claude's reasoning
原文の言語: 英語
メニュー
SkillsMP は nexvigilant/.true から 626 件の skill を収集しています。skill を開くとソースと詳細を確認できます。
収集済み skill 626 件中 40 件を表示しています。
Auto-apply Knowledge-Skills-Behaviors framework to guide Claude's reasoning
原文の言語: 英語
Thalidomide Legacy: Understanding the pivotal 1960s tragedy that catalyzed modern pharmacovigilance...
原文の言語: 英語
Regulatory Development: Evolution from reactive post-market observation to proactive safety systems...
原文の言語: 英語
Global Harmonization: ICH guidelines development and international regulatory convergence...
原文の言語: 英語
Technology Evolution: From paper-based reporting to AI-enhanced surveillance systems...
原文の言語: 英語
Population Health Impact: Understanding medication safety within broader public health frameworks...
原文の言語: 英語
Health Equity Considerations: Ensuring safety monitoring addresses diverse populations and access issues...
原文の言語: 英語
Pandemic Preparedness: Role of pharmacovigilance in emergency use authorizations and vaccine safety...
原文の言語: 英語
Global Health Perspective: Medication safety monitoring in resource-limited settings...
原文の言語: 英語
FDA Guidance: Understanding FAERS, FDA's role in post-market surveillance, and regulatory expectations...
原文の言語: 英語
EMA Framework: EU Pharmacovigilance legislation, GVP modules, and European regulatory approach...
原文の言語: 英語
ICH Guidelines: E2A through E2F implementation and global harmonization principles...
原文の言語: 英語
Regional Variations: PMDA (Japan), Health Canada, and emerging market regulatory approaches...
原文の言語: 英語
Core Ethical Principles: Beneficence, non-maleficence, autonomy, and justice in safety monitoring...
原文の言語: 英語
Informed Consent: Understanding patient rights in safety data collection and usage...
原文の言語: 英語
Transparency Standards: Balancing public disclosure with competitive and privacy considerations...
原文の言語: 英語
Professional Responsibility: Individual and organizational obligations for patient safety...
原文の言語: 英語
AI/ML Terminology: Machine learning, natural language processing, predictive analytics, neural networks...
原文の言語: 英語
Application Areas: Pattern recognition, signal detection, automated case processing, risk prediction...
原文の言語: 英語
Validation Requirements: Ensuring AI tools meet regulatory standards and maintain human oversight...
原文の言語: 英語
Ethical AI: Bias mitigation, transparency, explainability, and responsible implementation...
原文の言語: 英語
AI Impact on PV Landscape: Understanding of how artificial intelligence is transforming pharmacovigilance practice including au...
原文の言語: 英語
AI Ethics in Drug Safety: Comprehension of ethical considerations in AI-enabled pharmacovigilance including algorithmic transp...
原文の言語: 英語
PV AI Governance Frameworks: Understanding of governance structures required for AI in pharmacovigilance including organizational...
原文の言語: 英語
AI Competency Requirements: Understanding of evolving workforce competency requirements in AI-enabled pharmacovigilance includin...
原文の言語: 英語
PV AI Technology Ecosystem: Comprehensive understanding of the AI technology ecosystem relevant to pharmacovigilance including c...
原文の言語: 英語
AI System Validation Principles: Understanding of validation principles for AI systems in pharmacovigilance including GAMP 5 AI consi...
原文の言語: 英語
Type A Reactions: Dose-dependent, predictable, pharmacologically mediated responses...
原文の言語: 英語
Type B Reactions: Dose-independent, unpredictable, idiosyncratic responses...
原文の言語: 英語
Type C Reactions: Chronic effects from long-term exposure...
原文の言語: 英語
Type D Reactions: Delayed effects appearing after treatment discontinuation...
原文の言語: 英語
Type E Reactions: End-of-treatment withdrawal effects...
原文の言語: 英語
Type F Reactions: Failure of therapy due to drug interactions or resistance...
原文の言語: 英語
Pharmacokinetic Factors: Absorption, distribution, metabolism, excretion variations...
原文の言語: 英語
Pharmacodynamic Interactions: Receptor binding, dose-response relationships, therapeutic windows...
原文の言語: 英語
Drug-Drug Interactions: Synergistic, antagonistic, and additive effects...
原文の言語: 英語
Drug-Disease Interactions: Impact of comorbidities on drug safety profiles...
原文の言語: 英語
Pharmacogenetic Influences: Genetic polymorphisms affecting drug metabolism and response...
原文の言語: 英語
Causality Assessment Methods: WHO-UMC, Naranjo, Bradford-Hill criteria...
原文の言語: 英語
Temporal Relationship Analysis: Onset timing, dose-response patterns, dechallenge/rechallenge...
原文の言語: 英語